CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +500 | $150.78 | $75K | 500 |
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Sale | −100 | $503.76 | $50K | 400 |
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Sale | −400 | $505.78 | $202K | 0 |
| 2021-11-19 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Stock Option (Right to Buy) | −500 | 2,152 | ||
| 2021-11-16 | Eansor Norman David President-Protein Sciences | Option exercise | +799 | $125.05 | $100K | 2,117 |
| 2021-11-16 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −799 | 0 | ||
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Option exercise | +27,159 | $125.05 | $3.4M | 28,477 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −700 | $504.09 | $353K | 27,777 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −200 | $504.78 | $101K | 27,577 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −300 | $502.99 | $151K | 27,277 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −537 | $504.14 | $271K | 26,740 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −400 | $505.01 | $202K | 26,340 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −4,054 | $502.77 | $2.0M | 22,286 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −9,043 | $503.61 | $4.6M | 13,243 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −8,989 | $504.39 | $4.5M | 4,254 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −2,535 | $505.49 | $1.3M | 1,719 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Sale | −401 | $506.24 | $203K | 1,318 |
| 2021-11-12 | Eansor Norman David President-Protein Sciences | Option exercise · Stock Options (Right to Buy) | −27,159 | 799 | ||
| 2021-11-02 | Hippel James Chief Financial Officer | Option exercise | +200 | $125.05 | $25K | 10,955 |
| 2021-11-02 | Hippel James Chief Financial Officer | Sale | −200 | $525.10 | $105K | 10,755 |
Page 26 of 32 · 626 trades